Podcasts:

PLAYLIST TIME:

Latest News for: tumor tumor

Edit

Secarna Pharmaceuticals to present positive new data on antisense oligonucleotide SECN-15 targeting NRP1 as monotherapy and in combination with immune checkpoint inhibitors at AACR

Pharmiweb 26 Mar 2025
In mice treated with NRP1-specific ASOs, delayed tumor growth and complete tumor eradication were demonstrated ... upon tumor re-challenge, indicating induction of an anti-tumor memory immune response.
Edit

Nouscom to Present Final Results from Successful Phase Ib/II Trial of NOUS-209 in People Living with Lynch Syndrome, Demonstrating Powerful Potential to Intercept Cancer in its Earliest Stages of Development

Pharmiweb 26 Mar 2025
NOUS-209 is an off-the-shelf immunotherapy designed to target tumors with specific genetic deficiencies known as mismatch repair deficiency (dMMR) and/or microsatellite instability (MSI). These tumors ...
Edit

Letter: Women deserve the facts about abortion before choosing it

Detroit news 26 Mar 2025
18 hearing, one witness actually compared unborn children to an appendix and a tumor ... It is ludicrous to propose there is no difference between an unborn child and a tumor being removed ... and a tumor.
Edit

Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025

Pharmiweb 26 Mar 2025
In addition to its proprietary Amanitin-based ADC technology, Heidelberg Pharma has developed a diverse ADC toolbox designed to overcome tumor resistance through multiple mechanisms, enabling targeted treatment across various cancer types.
Edit

UP study shrinks breast cancer tumors

The Manila Times 26 Mar 2025
Their study showed that "the compound renieramycin M (RM), especially when combined with the clinically used cancer drug doxorubicin (Dox), significantly shrank tumors in mice while reducing the toxicity commonly associated with chemotherapy drugs.".
Edit

Lupus-related antibody shows promise in enhancing cancer treatment efficacy

Science Daily 26 Mar 2025
... tumors and flip on an immune response that has been turned off by cancer.
Edit

Avacta Therapeutics Announces Presentations at 2025 AACR Annual Meeting

Hastings Tribune 26 Mar 2025
... tumor, today announced that the Company will have three .
Edit

Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into a Clinical Study Agreement to Advance ...

ACCESSWIRE 26 Mar 2025
Xenetic's proprietary recombinant DNase I is an enzyme that digests NETs in a tumor microenvironment ... or metastatic solid tumors receiving chemotherapy and immunotherapy in Israeli medical centers.
Edit

\u2018New frontiers in cancer treatment:\u2019 Nebraska Medicine to establish proton therapy

The Daily Nebraskan 26 Mar 2025
Proton therapy focuses a targeted dose of radiation to treat tumors, in turn minimizing damage to surrounding tissue ... tumors are located on the brain, spine, heart or eyes, according to a release.
Edit

'Swifties for Lily': Taylor Swift fans support 13-year-old with terminal cancer diagnosis

Oakridger 26 Mar 2025
Swifties send friendship bracelets to 13-year-old with brain tumor ... The incurable and terminal disease is a rare and aggressive brain tumor found on the brain stem.
Edit

Asgard Therapeutics appoints immunology expert Shane Olwill as Chief Development Officer

Pharmiweb 26 Mar 2025
AT-108 is a first-in-class, off-the-shelf cell reprogramming therapy that forces tumor cells to present their own tumor antigens, inducing a personalized immune response tailored to target each patient’s cancer ... .
Edit

Marengo to Share Updated Clinical Data of Invikafusp Monotherapy Activity in PD1 resistant tumors in ...

The Eagle-Tribune 26 Mar 2025
Data to be presented from the STARt-001 trial demonstrating single agent anti-tumor activity ... .
Edit

Dewpoint Therapeutics announces upcoming presentations at AACR 2025

Hastings Tribune 26 Mar 2025
Dewpoint will present two posters at AACRCondensate modulators (c-mods) demonstrate robust anti-tumor effects across multiple types of cancerC-mods modulate the oncogenic function of historically undruggable targets MYC and beta catenin ... .
×